Importantly, our results are in agreement with current understanding of the drivers of metastasis in breast cancer -- proliferation for ER+/HER2-, immune response for ER-/HER2-, and tumour invasion and immune response for HER2+ [51] -- suggesting our approach could be a useful one. This evidence concerns the gene ESR1 and breast carcinoma.